We demonstrated recently that isoproterenol enhanced the cardiac voltage-dependent sodium currents (IN.) in rabbit ventricular myocytes through dual G-protein regulatory pathways. In this study, we tested the hypothesis that isoproterenol reverses the sodium channel blocking effects of class I antiarrhythmic 
Introduction
Approximately 80% of the 350,000 deaths each year from sudden cardiac arrest in this country are due to ventricular tachyarrhythmias (1) . Sodium channel-blocking antiarrhythmic drugs (class I) are the most commonly used pharmacological agents for the treatment of life-threatening ventricular arrhythmias.
However, recurrence of ventricular tachyarrhythmias remains high (up to 32% in 2 yr) in patients treated with class I antiarrhythmic drugs that show suppression of ventricular tachyarrhythmias induced by programmed electrical stimulation (2) . The decline in drug efficacy during long-term follow-up is probably multifactorial and may be due to inconsistent patient compliance in drug administration, change in myocardial substrate in patients with coronary artery disease, concurrent disease states that may affect drug metabolism, proarrhythmic and adverse hemodynamic effects of antiarrhythmic drugs (3) , and interaction with drug metabolites or with other concurrent drugs that may reduce the effects of antiarrhythmic drugs (4) .
In addition, f3-adrenergic catecholamines, whether in blood circulation or released locally from sympathetic nerve endings, may be important in the modulation of antiarrhythmic drug effects.
It is well known that f3-adrenergic stimulation is important in the pathogenesis of ventricular tachyarrhythmias (5) . Isoproterenol has been shown to facilitate induction ofventricular tachyarrhythmias in patients whose clinical arrhythmias could not be induced by programmed electrical stimulation (6, 7) . Beta-adrenergic blockade is known to protect patients against sudden cardiac death after a myocardial infarction (8) and addition of 3-blockers to class I antiarrhythmic drugs has been demonstrated to provide further protective effects against induction of ventricular tachycardia and its recurrence (9) . More recently, clinical electrophysiological studies reported fl-adrenergic catecholamines could reverse the protective effects of class I antiarrhythmic drugs that have been shown to be efficacious by programmed electrical stimulation (10, 11) . Patients presented with sudden cardiac arrest and recurrent syncope due to rapid ventricular tachycardia showed a high propensity for isoproterenol-induced antiarrhythmic reversibility (80 and 62.5%, respectively) (10) . The mechanism by which isoproterenol reverses the antiarrhythmic effects of sodium channel-blocking drugs is unknown.
Beta-adrenergic catecholamines are known to modulate the activities of a number of membrane ionic currents in cardiac cells (12) . These include the slow-inward calcium current (13) , the pacemaker current in the sinoatrial node, If ( 14) , the chloride current (15, 16) , the transient outward potassium current (17) , the delayed rectifer potassium current (18) , and an Na'-dependent inward current (19) . Although fl-adrenergic modulation of these ion currents may significantly alter the electrophysiological properties of the heart and may facilitate development of arrhythmias, direct demonstration that such fl-adrenergic effects modulate antiarrhythmic drug action has not been previously reported. Recently, we demonstrated that myocytes are enhanced by isoproterenol (20) . The enhancement of INa by isoproterenol is mediated both through direct stimulatory effects of G,,, and indirect cAMP-dependent phosphorylation mechanisms. In this study, we tested the hypothesis that the enhancement of INa by isoproterenol is responsible for the reversal of suppression. of INa by class I antiarrhythmic drugs and that the reversal of such effects should be reflected by changes in impulse conduction velocities in the ventricular myocardium. We measured the effects oflidocaine and isoproterenol on INa in isolated rabbit ventricular myocytes using patch-clamp techniques. The effects oflidocaine and isoproterenol on epicardial impulse conduction velocities were measured using an epicardial mapping system in Langendorff-perfused isolated rabbit hearts.
Methods
Isolation ofventricular myocytes. Isolated rabbit ventricular myocytes were obtained by enzymatic dissociation through retrograde coronary perfusion with 0.017 mg/ml protease (type XXIV; Sigma Chemical Co., St. Louis, MO) as described previously (20) . After 10 min of enzyme perfusion at 371C, 2 mm X 2 mm pieces of myocardium were removed from the ventricles and further digested with collagenase (type I, 0.6 mg/ml; Sigma Chemical Co.) in a nominally zero-CaCl2 solution with the following composition (mM): 140 NaCl, 4.5 KCl, 1.0 MgCl2, 10 Hepes, and 5.55 glucose, pH 7.4. After 5 min ofincubation at 350C, the tissue segments were rinsed with at least five aliquots of zero-CaCl2 solution and single cells were dissociated by mild mechanical trituration. Elongated, striated, and Ca++-tolerant single myocytes were used for the experiments. These cells were quiescent without spontaneous contractile activities and had resting membrane potentials between -75 and -89 mV. All cellular experiments were performed within 6 h of cell isolation. Cellular electrophysiological techniques. Voltage-dependent INa in isolated cardiac ventricular myocytes were measured using patchclamp techniques as described previously (20, 21) . Bath solutions were superfused using a direct current-powered pump (Cole-Palmer Instrument Co., Chicago, IL) at a rate of 1 to 2 ml/min and solution exchanges were complete within 30 to 60 s. Whole-cell INa was recorded with an integrating amplifier (Axopatch IC or Axopatch 200; Axon Instruments, Foster City, CA), visualized on-line using a digital oscilloscope, filtered with a four-pole low pass Bessel filter with a bandwidth (-3 dB) of 2 kHz and sampled at 25 kHz using a 12-bit resolution A/D converter. pClamp software (Axon Instruments) was used for generating voltage-clamp protocols and for the acquisition and analysis of IN. using an IBM-compatible 80386-based personal computer. Whole-cell studies were performed with a bath solution with the following composition (mM): 20 NaCl, 100 tetramethylammonium chloride, 20 tetraethylammonium chloride, 4.5 KCl, 1.0 MgC12, 2.0 CaCl2, 1.0 BaCl2, 2.0 CoCl2, 10.0 Hepes, and 5.55 glucose, pH 7.35. The pipette solution for whole-cell recording had the following composition (mM): 130 CsCl, S Na2ATP, 0.5 GTP, 5 EGTA, 0.5 CaCl2, 2 MgC12, and 10 Hepes, pH 7.25. All cellular electrophysiology experiments were performed at room temperature (21-23°C). Time-dependent changes ofINa consisting of shifts of inactivation in the hyperpolarizing direction were frequently observed (22) (23) (24) (25) Epicardial conduction velocity recordings. Isolated rabbit hearts were maintained on a Langendorff apparatus as described previously (27) . The hearts were perfused at 25 ml/min with a buffer ofthe following composition (mM): 140 NaCl, 4.5 KCl, 1 MgCl2, 2 CaCl2, 20 glucose, 0.5 NaH2PO4, 10 Hepes, pH 7.40 at 370C equilibrated with 100% 02. A 30-min equilibration period was instituted before any mapping procedure or experimental intervention was performed. For epicardial conduction velocity recordings, a custom-made electrode array was mounted onto the anterolateral surface of the left ventricle using an adjustable girdle. The electrode array consisted of 25 gold-plated coaxial bipolar electrodes arranged in a square lattice spaced 2 mm from each other. Pacing was performed via bipolar electrode sites on the periphery of the electrode array with 2-ms current pulses at twice the diastolic threshold using an electronic stimulator (Bloom Associates, Reading, PA) at a rate sufficient to overdrive spontaneous activities (cycle lengths 250-300 ms). Pacing sites were selected according to the isochronal activation maps generated that allowed analysis of transverse and longitudinal conduction velocities. The average ventricular effective refractory period was 177.5±5.4 ms. Perfusion of drugs was allowed to reach steady state (10-15 min for lidocaine and 5-10 min for lidocaine plus isoproterenol) before mapping was performed. After drug intervention, the heart was perfused with control buffer for 30 min and mapping performed to ensure reversibility of drug effects on wash out. Activation times at the recording sites were acquired using a mapping system (BARD Electrophysiology; C. R. Bard, Billerica, MA). Data were stored on the computer hard disk. Analysis of activation times was performed using the BARD software. The activation times for all the beats were automatically assigned by the computer program and marked as the maximum voltage deflection of the bipolar electrogram. All activations were subsequently edited by the same investigator to maintain consistency in activation time measurements. Activation sequence maps with isochronal activation lines at 5-or 10-ms intervals were generated by the BARD software, displayed on the monitor, and printed for future reference. Conduction velocities were calculated by measuring the distance between sites along the longitudinal and transverse axes divided by the difference in activation times. The concentrations of drugs used in these experiments were within the therapeutic ranges used in humans (10 1AM of lidocaine was equivalent to 1.7 ,gg/ ml; 0.05 MM of isoproterenol was equivalent to 0.3 ,gg/min).
Statistical analysis. All data were expressed as mean±SEM and significance was determined by paired t test at P < 0.05.
Results
To ensure adequate voltage control, whole-cell INa studies were performed with reduced external Na' as previously described (20) . Under these conditions, 65 AM oflidocaine showed rapid suppression of INa and the lidocaine effects were significantly reversed by 1 AM of isoproterenol ( Fig. 1 ). Upon removal of isoproterenol, INa returned to the previous suppressed current amplitude with lidocaine application alone. In addition, INa returned to the original drug-free baseline on wash out of lidocaine ( Fig. 1 (Fig. 2, top) . At a holding potential of -80 mV, the same pulse protocol resulted in the development of significant use-dependent INa block. These results showed that the amount of block from use dependence was greater than the amount of tonic block (Fig. 2, bottom) , which was represented by the peak INa amplitude elicited by the first pulse of the train with intertrain intervals of > 30 s. The same pulse train at a holding potential of -100 mV elicited intermediate amounts ofuse-dependent INa block (Fig. 2, middle) . These results are consistent with the current concepts that antiarrhythmic drug actions of sodium channel blockade are voltage dependent (28) . This effect is probably due to the voltage dependence of sodium channel repriming as previous reported (26) . The frequency-dependent reduction of INa observed during baseline at a holding potential of -80 mV can also be explained by the kinetics of sodium channel repriming (Fig. 2, lower) . At -80 mV, INa does not recover completely from inactivation with a recovery interval of 250 ms (see Fig. 5 , bottom), resulting in frequency-dependent accumulation of channel inactivation. The ability of isoproterenol (1 MM) to reverse lidocaine blockade of cardiac INa is also dependent on membrane potential (Fig. 2) . At a holding potential of -120 mV, 1 MM of isoproterenol completely reversed the tonic block and significantly reversed the use-dependent block of INa by 65 AM of lidocaine (Fig. 2, top) whereas at a holding potential of -80 mV, 1 MM of isoproterenol showed little reversal of the tonic or use-dependent INa block by lidocaine (Fig. 2, bottom) . At a holding potential of ,- (Fig. 2, middle) . Time (ms) Figure 5 . Effect of lidocaine (65 MM) and isoproterenol (1 AM) on recovery from inactivation of IN. using a two-pulse paradigm. Three holding potentials are studied: -120 (top, n = 4), -100 (middle, n = 4), and -80 mV (bottom, n = 6). Conditioning pulses at 0 mV of 500-ms duration are followed by testing pulses at -35 mV of 40-ms duration with an intertrain interval of 5 s. For holding potentials of -120 and -100 mV, the interpulse intervals are between 1 (26) . Lidocaine (65 AM) significantly reduced the amplitude of the fast component and increased the amplitude ofthe slow component of sodium channel recovery (P < 0.005 for Amp 1 and Amp 2 at all three potentials compared with respective values at baseline). This is consistent with the current concept that the fast component represents recovery of unblocked channels and the slow component represents recovery ofblocked channels (29) . Lidocaine did not alter Tr at -120 and -100 mV but significantly prolonged x, at -80 mV (P = 0.015 compared with baseline, n = 6) and lidocaine significantly prolonged T2 at -100 and -80 mV ( To confirm the physiological relevance of the observations in isolated cardiac myocytes, we studied the effects ofisoproterenol on lidocaine suppression of conduction velocities. These studies were performed in isolated rabbit hearts using an epicardial mapping system as described in Methods. Using such a setup, the control conduction velocities were 0.585±0.001 m/s (n = 7) in the longitudinal direction (OL) and 0.257±0.014 m/s in the transverse direction (CT) (n = 8) (Fig. 6) . These results are in agreement with reported values from other laboratories with different species (30, 31) . Lidocaine (10 ,uM) These results are consistent with the findings of INa in isolated cardiac myocytes. However, the effect of lidocaine on conduction velocities is anisotropic; the depression ofCL by lidocaine is greater than that of CT. The ratio of CL/CT was significantly lower in the presence of lidocaine (from 2.39±0.20 at baseline vs. 2.15±0.20 with lidocaine, n = 6, P < 0.05). These results were consistent with previous observations in canine myocardium (32) . On the other hand, the effects of isoproterenol were not anisotropic (CL/CT = 2.28±0.24, n = 6, P = NS compared with lidocaine alone), suggesting that the site of isoproterenol action on the sodium channel was different from that of lidocaine.
Discussion
The major new finding ofthe present study is that f3-adrenergic stimulation reverses lidocaine suppression ofcardiac INa. Lidocaine was chosen because it is a prototype sodium channel blocking antiarrhythmic drug and its effects in heart and heart cells have been well characterized (26, (32) (33) (34) (35) (36) . Sodium channel blockade is thought to result from binding of lidocaine to specific receptors in the sodium channel in both activated and inactivated states (35) . Single sodium channel studies in mammalian cardiac myocytes showed that lidocaine reduces both the number ofopen channel events and the average duration of opening for each event (36) . Furthermore, the effects of lidocaine on conduction velocities in the intact heart has been characterized (32). Our study shows that reversal of the lidocaine effects on the rabbit INa by isoproterenol is observed both in isolated cardiac myocytes and isolated hearts.
In contrast to the effects of isoproterenol on the cardiac calcium and potassium channels, which have been well characterized, much less information is available regarding ,B-adrenergic effects on the cardiac INa. Conflicting results have been (28) . We found that the two components of sodium channel recovery from inactivation are similar to those described by Bean et al. (26) . At normal or hyperpolarized potentials (-120 and -100 mV), lidocaine does not change the time constant of the fast recovery component (r1) but decreases its contribution. On the other hand, lidocaine increases both the contribution ofthe slow recovery component and prolongs its time constant. At HPs of -80 mV, lidocaine prolongs TI, suggesting the kinetics ofINa recovery in partially depolarized tissue are more complex and may be better described with more than two exponential components. However, detailed analysis of INa recovery kinetics is beyond the scope of the present study. Isoproterenol exhibits no significant effects on the fast or the slow component ofINa recovery in the presence oflidocaine. Lidocaine shifts the INa inactivation curve in the hyperpolarizing direction and isoproterenol has no effect on the normalized steady state inactivation curve. These results suggest that isoproterenol does not affect lidocaine binding and unbinding to the sodium channel receptor site. Among the various potential mechanisms for isoproterenol to reverse the suppressive effects of lidocaine on the sodium channel, an increase in channel recruitment is a distinct possibility as sodium channel availability is increased (Fig. 4 A) . Detailed mechanisms involved in the reversal of the lidocaine blockade of IN. by isoproterenol, however, will require further studies using single sodium channel recordings.
Reversal oflidocaine effects on conduction velocities in isolated hearts. The epicardial conduction experiments were performed to further investigate the physiological significance of the whole-cell INa studies. These studies were performed under physiological electrolyte compositions and temperature. Suppression of INa by lidocaine and reversal of the lidocaine effect by isoproterenol should be reflected by changes in impulse conduction velocities. Wallace (8, 9) . Although we believe our findings are of major importance in depicting the fl-adrenergic reversal of antiarrhythmic drug effects, we would like to acknowledge other potential mechanisms that may also contribute to such 13-adrenergic effects. Beta-adrenergic stimulation is known to modulate a number of ionic channels (12) in the heart and has profound effects on the cardiac action potential (5). The delayed rectifier IK in both mammalian and amphibian hearts (18, 49) , the transient outward current I,. (17) , and the chloride current (15, 16) are known to be activated by isoproterenol and by intracellular application of cAMP or the catalytic subunit of protein kinase A. Blockers of the inactivated sodium channels would become less effective as these channels are activated and the cardiac action potential duration becomes shorter. Activation of the Na+/K' pump by f3-adrenergic stimulation will lead to hyperpolarization of the membrane potential (50) , which may diminish the amount of tonic and use-dependent INa block, as well as improve recovery of the sodium channel from blockade by antiarrhythmic drugs like lidocaine. These fl-adrenergic effects on cardiac ion channels can therefore compromise antiarrhythmic drug action independent of the effects on the sodium channel. On the other hand, activation of the Na'-dependent inward current (19) would cause depolarization of membrane potential with greater IN. block by drug and may produce toxic side effects, including proarrhythmia. Beta-adrenergic stimulation is also known to facilitate certain types of cardiac arrhythmias, including delayed afterdepolarizations through intracellular Ca`+ overload (51) and ventricular fibrillation through increase in cAMP (52, 53) . The daily fluctuations of body catecholamine levels may therefore play an important role not only in the modulation ofantiarrhythmic drug action but also in the pathogenesis ofarrhythmias that may jeopardize the long-term survival of patients on class 1 antiarrhythmic drugs for treatment of life-threatening ventricular arrhythmias. In addition, chronic administration of antiarrhythmic drugs may result in parent drug-metabolite interaction that may diminish the efficacy ofantiarrhythmic drugs. Glycylxylidide, a deethylated metabolite of lidocaine that accumulates in patients on lidocaine therapy, competes with lidocaine for the same sodium channel receptor but has different kinetics of recovery from block. Glycylxylidide has been shown to competitively displace its parent compound in vitro, producing a significant increase in INa (54) . Beta-adrenergic stimulation has been shown to restore conduction velocities in tissues where conduction is depressed, e.g., ischemic and partially depolarized myocardium (45) . This is similar to our findings in isolated rabbit hearts where conduction depressed by lidocaine is restored by isoproterenol.
Other than the effects on conduction velocity, fl-adrenergic stimulation may augment development of ventricular arrhythmias, both spontaneous and induced, through shortening of refractoriness (55) so that premature depolarizations can be more closely coupled to allow better penetration of reentry circuits.
Our observation that isoproterenol reversal of lidocaine effects on INa is voltage dependent suggests that (3-adrenergic stimulation is potentially arrhythmogenic in hearts with ischemic disease. Heterogeneity of impulse conduction in partially depolarized tissue may predispose the heart to development of conduction block and reentry. The spatial nonuniformity in excitability and recovery of excitability may also give rise to ventricular fibrillation. Indeed, rate-dependent conduction velocity depression and nonuniform activation are identified as important determinants for the genesis of ventricular arrhythmias (32) . Isoproterenol with a drug like lidocaine may further exaggerate such nonuniformity and predispose the ischemic heart to lethal arrhythmias.
In summary, the fl-adrenergic-mediated antagonistic effects to class 1 antiarrhythmic drugs are likely to involve multiple factors. Nevertheless, the present study provides the first direct evidence that INa modulation significantly contributes to such f3-adrenergic effects.
